Filing Flows › Amphastar Pharmaceuticals (AMPH) › Operating margin
Amphastar Pharmaceuticals (AMPH) operating margin by quarter
Amphastar Pharmaceuticals' operating margin was 24.5% in Q3 2026 (third quarter 2026), +2.9 pts from Q2 2026. Over the last 7 quarters it ranged from 8.0% (Q1 2026) to 24.5% (Q3 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 24.5% | +2.9 pts | +11.3 pts |
| Q2 2026 | 21.6% | +13.6 pts | -2.6 pts |
| Q1 2026 | 8.0% | -11.5 pts | -13.9 pts |
| Q4 2025 | 19.4% | +6.2 pts | — |
| Q3 2025 | 13.2% | -11.0 pts | — |
| Q2 2025 | 24.2% | +2.3 pts | — |
| Q1 2025 | 21.9% | — | — |
Q3 2026 at a glance
Amphastar Pharmaceuticals, Q3 2026: revenue $208M (+8% year over year), operating margin 24.5%, net earnings $37.8M, operating cash flow $43.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Amphastar Pharmaceuticals' operating margin?
Amphastar Pharmaceuticals' operating margin was 24.5% in Q3 2026 (third quarter 2026), +2.9 pts from Q2 2026.
How has Amphastar Pharmaceuticals' operating margin changed?
Over the last 7 quarters it ranged from 8.0% (Q1 2026) to 24.5% (Q3 2026).
Q3 2026 results → · How Amphastar Pharmaceuticals makes money →